Effectiveness of glycopyrronium bromide in the treatment of small airway dysfunction: A retrospective study.
Albino PetroneCorrado PelaiaMichela QuartieriLudovico PetroneGiuseppe Francesco RagoClementina ColumbroGirolamo PelaiaPublished in: SAGE open medicine (2022)
Small airway dysfunction is associated with bronchodilator responsiveness. Glycopyrronium bromide has proven to be capable of inducing favorable effects on lung hyperinflation and its functional and clinical consequences, with a decrease in dyspnea and an increase in exercise capacity. The use of anticholinergic drugs is useful in the management of small airway disease.